CD274 and lung carcinoma: We found that CD274 (PD-L1) levels by different probes presented inconsistent results, whereas CD274 by probe 223834_at associates with a poor survival rate (p < 0.05) but probe 227458_at with a better survival rate (p < 0.05) in patients with lung cancer (Fig. 2G).